SHELBY BOLLINGER: Open Payments
NPI 1659941219 · SIKESTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,201 in 52 payments from 10 companies in 2025. Trend: 2023 $1,454 · 2024 $1,065 · 2025 $1,201
Food & beverage: $1,201
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 17 | $380 |
| ABBVIE INC. | 17 | $280 |
| Teva Pharmaceuticals USA, Inc. | 6 | $205 |
| Janssen Pharmaceuticals, Inc | 2 | $139 |
| Neurocrine BioSciences, Inc. | 3 | $54 |
| E.R. Squibb & Sons, L.L.C. | 2 | $40 |
| Vanda Pharmaceuticals Inc. | 2 | $39 |
| Braeburn Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $20 |
Products named: ARISTADA, VRAYLAR, UZEDY, SPRAVATO, INGREZZA, COBENFY, FANAPT, BRIXADI.
Industry payments across MO — which companies pay providers there.
